Abeta 1-42 antibody (PE-Cy7)
-
- Target See all Abeta 1-42 Antibodies
- Abeta 1-42 (Amyloid beta 1-42 (Abeta 1-42))
-
Reactivity
- Human, Rat
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Abeta 1-42 antibody is conjugated to PE-Cy7
-
Application
- Western Blotting (WB)
- Cross-Reactivity
- Human, Rat
- Purification
- Purified by Protein G.
- Immunogen
- KLH conjugated synthetic peptide derived from human beta-Amyloid (1-42)
- Clone
- 1F4
- Isotype
- IgG
- Top Product
- Discover our top product Abeta 1-42 Primary Antibody
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- Abeta 1-42 (Amyloid beta 1-42 (Abeta 1-42))
- Alternative Name
- beta-Amyloid 1-42 (Abeta 1-42 Products)
- Synonyms
- amyloid beta precursor protein antibody, App antibody, APP antibody
- Background
-
Synonyms: NULL
Background: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
- Gene ID
- 351
-